Searchable abstracts of presentations at key conferences in endocrinology

ea0050ec1.1 | Alternative career pathways | SFEBES2017

A career in pharma

Challis Ben

The pharmaceutical industry provides challenging and rewarding career opportunities for physicians. Given that clinical drug development for cardio-metabolic and oncological indications are the focus for many pharmaceutical companies, physicians and scientists with specialist training in endocrinology, diabetes and metabolism are in demand. In addition to responsibilities in clinical trial design, drug safety and regulatory affairs, physician scientists with an intimate knowle...

ea0050ec1.1 | Alternative career pathways | SFEBES2017

A career in pharma

Challis Ben

The pharmaceutical industry provides challenging and rewarding career opportunities for physicians. Given that clinical drug development for cardio-metabolic and oncological indications are the focus for many pharmaceutical companies, physicians and scientists with specialist training in endocrinology, diabetes and metabolism are in demand. In addition to responsibilities in clinical trial design, drug safety and regulatory affairs, physician scientists with an intimate knowle...

ea0044p127 | Neoplasia, cancer and late effects | SFEBES2016

A review of the diagnostic sensitivity of plasma metanephrine testing in patients with SDH gene mutations

Abraham Shalin , Casey Ruth , Pitfield Deborah , Challis Ben , Simpson Helen

Phaeochromocytomas (PC) are tumours of the adrenal medulla and paragangliomas (PGL) refer to their extra-adrenal counterpart arising from sympathetic or parasympathetic tissue. Mutations in the citric acid cycle enzyme succinate dehydrogenase (SDH) predispose to PC/PGL. Clinical practice guidelines suggest that plasma metanephrine and normetanephrine levels measured in the supine position should be used in the first instance for biochemical diagnosis, and those with positive r...

ea0052p39 | (1) | UKINETS2017

A case of carcinoid crisis despite high dose somatostatin analogue therapy peri-operatively

Pitfield Deborah , Casey Ruth , Seetho Ian , Shaw Ashley , Buscombe John , Roe Paul , Buczacki Simon , Challis Ben

Introduction: Carcinoid crisis is a life threatening endocrine emergency. It remains unclear whether there is an optimal dose of prophylactic somatostatin analogue (SSA) therapy in the peri-operative periodCase Study: A 62 year old lady with a new diagnosis of metastatic carcinoid disease was electively admitted for a right hemicolectomy for a well differentiated neuroendocrine tumour in the terminal ileum. A multi-disciplinary decision was made to offer...

ea0069oc3 | Oral Communications | SFENCC2020

A rare case of bilateral carotid body paragangliomas and associated Burkitt’s lymphoma in patient with a germline SDHB mutation

MacFarlane James , Bisambar Chad , Challis Ben , Park Soo-Mi , Giger Olivier , Aloj Luigi , Casey Ruth

Section 1&2: Case history and investigations: We report the case of a 52-year-old man with recurrent immunodeficiency-related Burkitt’s lymphoma. 11 years following remission of his disease he presented with a firm lump in the parotid region. A biopsy showed histopathological evidence of a relapse. An 18F FDG PET was undertaken to determine the extent of the disease and response to R-DHAX chemotherapy. Areas of high uptake were identified in both sides of t...

ea0062oc8 | Oral Communications | EU2019

Adenoma to carcinoma progression of a deoxycortisol-secreting adrenal cortical carcinoma in a 71 year old man presenting with hypokalaemia

Talbot Fleur , Powlson Andrew , Marker Alison , Gurnell Mark , Kosmoliaptsis Vasilis , Challis Ben , Casey Ruth

Case history: We present a 71 year old man, with a 3 year history of problematic hypertension (BP exceeding 190/100 on treatment), incidentally found to be hypokalaemic (K 1.8 mmol/l) during investigations for leg weakness. He had no clinical features to suggest an endocrinopathy. Investigations at his local centre revealed hypokalaemia dating back over 3 years.Investigations: Biochemistry:Na 142 mmol/l (135–145 mmol/l)<p ...

ea0044p126 | Neoplasia, cancer and late effects | SFEBES2016

Radiological surveillance in multiple endocrine neoplasia type 1: A double edged sword?

Casey Ruth , Saunders Debbie , Challis Ben , Pitfield Deborah , Cheow Heok , Shaw Ashley , Simpson Helen

Multiple endocrine neoplasia type 1 (MEN1) is a hereditary condition characterised by the predisposition to hyperplasia or the development of solitary adenomas of multiple endocrine gland. MEN1 related disease is responsible for death in two thirds of patients with this hereditary condition and the mean age at death is 55 years. This associated mortality necessitates a vigorous surveillance protocol, however all recommendations for radiological surveillance are based on non-pr...

ea0059oc1.5 | Translational highlights | SFEBES2018

In vivo and ex vivo metabolomics in succinate dehydrogenase deficient tumorigenesis

Casey Ruth , Basetti Madhu , McLean Mary , Challis Ben , Gallagher Ferdia , Maher Eamonn

Mutations affecting the mitochondrial enzyme succinate dehydrogenase (SDH) are associated with a wide spectrum of tumours. SDH deficient tumours have a unique tumour metabolome due to the interruption of the citric acid cycle and accumulation of the ‘oncometabolite’ succinate, which drives tumourigenesis. Investigating the tumour metabolome of SDH deficient tumours has potential translational application. MRI spectroscopy (1H-MRS) was used for in vivo<...

ea0038oc5.3 | Thyroid and parathyroid | SFEBES2015

Use of 11C-methionine PET to localise parathyroid adenoma/hyperplasia: a single centre experience

Challis Ben , Saad Ziauddin , Cheow H K , Buscombe John , Simpson Helen

Introduction: It is established practice to localise parathyroid lesions preoperatively using ultrasound (US) and sestaMIBI (MIBI). Whilst these imaging techniques have good sensitivity/specify, there are patients in which imaging does not localise a parathyroid lesion. 11C-Methionine PET (MET PET) is an imaging modality where 11C-methionine, a radioactive tracer, is taken up at sites of protein/peptide synthesis and has been demonstrated to be effective ...

ea0031p196 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Cellular consequences for insulin signal transduction of the naturally occurring AKT2 p.Glu17Lys mutation

Minic Marina , Rocha Nuno , Challis Ben , Groeneveld Matthijs , Rahilly Stephen O' , Semple Robert

Introduction: We have reported a syndrome of hypoketotic hypoglycaemia due to the de novo p.Glu17Lys mutation in AKT2, a serine threonine kinase central to insulin signalling. We aimed to evaluate further the physiological and cellular consequences of the p.Glu17Lys mutation.Results: Two previously reported 17-year-old men heterozygous for the AKT2 p.Glu17Lys mutation, each of whom had experienced severe fasting hypoglycaemia in early life, were...